Search research articles
Contact Us
Filters
Showing results (561-570 of 711) with videos related to
Page
of 72
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 13, 2002
A phase I study of pivaloyloxymethyl butyrate, a prodrug of the differentiating agent butyric acid, in patients with advanced solid malignancies
Amita Patnaik, Eric K Rowinsky, Miguel A Villalona, et al.
Frontiers in Immunology
|
June 27, 2022
Fc-Mediated Functions of Porcine IgG Subclasses
Basudev Paudyal, William Mwangi, Pramila Rijal, et al.
Stem Cell Reports
|
August 7, 2018
High-Resolution Single-Cell DNA Methylation Measurements Reveal Epigenetically Distinct Hematopoietic Stem Cell Subpopulations
Tony Hui, Qi Cao, Joanna Wegrzyn-Woltosz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 20, 2005
Phase I and pharmacokinetic study of sequences of the rebeccamycin analogue NSC 655649 and cisplatin in patients with advanced solid tumors
Alejandro D Ricart, Lisa A Hammond, John G Kuhn, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc
|
May 14, 2014
Imaging features of benign and malignant ampullary and periampullary lesions
Paul Nikolaidis, Nancy A Hammond, Kevin Day, et al.
Plos One
|
April 19, 2024
Protocol for a magnetic resonance imaging study of participants in the fever RCT: Does fever control prevent brain injury in malaria?
Moses B Chilombe, Karl B Seydel, Colleen A Hammond, et al.
Cancer Chemotherapy and Pharmacology
|
February 28, 2008
Cantuzumab mertansine in a three-times a week schedule: a phase I and pharmacokinetic study
Jordi Rodon, Mitchell Garrison, Lisa A Hammond, et al.
Investigational New Drugs
|
September 15, 2010
Phase I and pharmacokinetic study of 3'-C-ethynylcytidine (TAS-106), an inhibitor of RNA polymerase I, II and III,in patients with advanced solid malignancies
Lisa A Hammond-Thelin, Melanie B Thomas, Michiko Iwasaki, et al.
Glycobiology
|
June 11, 2004
Production of a complement inhibitor possessing sialyl Lewis X moieties by in vitro glycosylation technology
Lawrence J Thomas, Krishnasamy Panneerselvam, David T Beattie, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
April 28, 2006
Host response and dysfunction in the CNS during chronic simian immunodeficiency virus infection
Eleanor S Roberts, Salvador Huitron-Resendiz, Michael A Taffe, et al.
Page
of 72
Search research articles
Search
Showing results (561-570 of 711) with videos related to
Sort By:
Page
of 72
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 13, 2002
A phase I study of pivaloyloxymethyl butyrate, a prodrug of the differentiating agent butyric acid, in patients with advanced solid malignancies
Amita Patnaik, Eric K Rowinsky, Miguel A Villalona, et al.
Frontiers in Immunology
|
June 27, 2022
Fc-Mediated Functions of Porcine IgG Subclasses
Basudev Paudyal, William Mwangi, Pramila Rijal, et al.
Stem Cell Reports
|
August 7, 2018
High-Resolution Single-Cell DNA Methylation Measurements Reveal Epigenetically Distinct Hematopoietic Stem Cell Subpopulations
Tony Hui, Qi Cao, Joanna Wegrzyn-Woltosz, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 20, 2005
Phase I and pharmacokinetic study of sequences of the rebeccamycin analogue NSC 655649 and cisplatin in patients with advanced solid tumors
Alejandro D Ricart, Lisa A Hammond, John G Kuhn, et al.
Radiographics : a Review Publication of the Radiological Society of North America, Inc
|
May 14, 2014
Imaging features of benign and malignant ampullary and periampullary lesions
Paul Nikolaidis, Nancy A Hammond, Kevin Day, et al.
Plos One
|
April 19, 2024
Protocol for a magnetic resonance imaging study of participants in the fever RCT: Does fever control prevent brain injury in malaria?
Moses B Chilombe, Karl B Seydel, Colleen A Hammond, et al.
Cancer Chemotherapy and Pharmacology
|
February 28, 2008
Cantuzumab mertansine in a three-times a week schedule: a phase I and pharmacokinetic study
Jordi Rodon, Mitchell Garrison, Lisa A Hammond, et al.
Investigational New Drugs
|
September 15, 2010
Phase I and pharmacokinetic study of 3'-C-ethynylcytidine (TAS-106), an inhibitor of RNA polymerase I, II and III,in patients with advanced solid malignancies
Lisa A Hammond-Thelin, Melanie B Thomas, Michiko Iwasaki, et al.
Glycobiology
|
June 11, 2004
Production of a complement inhibitor possessing sialyl Lewis X moieties by in vitro glycosylation technology
Lawrence J Thomas, Krishnasamy Panneerselvam, David T Beattie, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
April 28, 2006
Host response and dysfunction in the CNS during chronic simian immunodeficiency virus infection
Eleanor S Roberts, Salvador Huitron-Resendiz, Michael A Taffe, et al.
Page
of 72